DrugPatentWatch Database Preview
Details for Patent: 10,076,614
Which drugs does patent 10,076,614 protect, and when does it expire?
Patent 10,076,614 protects ONZETRA XSAIL and XHANCE and is included in two NDAs.
This patent has seventeen patent family members in thirteen countries.
Summary for Patent: 10,076,614
| Title: | Nasal delivery devices |
| Abstract: | A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing (15); a nosepiece (17) for fitting to a nasal cavity of the subject; a mouthpiece (19) through which the subject in use exhales; and a flexible coupling (20) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece. |
| Inventor(s): | Djupesland; Per Gisle (Oslo, NO), Gordon; Joseph (Mansfield, MA), Leclerc; Michael (Cranston, RI), Mahmoud; Ramy A (Skillman, NJ), Siwinski; Shane (Providence, RI) |
| Assignee: | OptiNose AS (Oslo, NO) |
| Application Number: | 14/380,801 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; |
Drugs Protected by US Patent 10,076,614
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Optinose Us Inc | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,076,614
| PCT Information | |||
| PCT Filed | February 25, 2013 | PCT Application Number: | PCT/EP2013/053747 |
| PCT Publication Date: | August 29, 2013 | PCT Publication Number: | WO2013/124492 |
International Family Members for US Patent 10,076,614
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013223973 | Start Trial | |||
| Canada | 2865353 | Start Trial | |||
| China | 104428026 | Start Trial | |||
| European Patent Office | 2817054 | Start Trial | |||
| Hong Kong | 1205699 | Start Trial | |||
| India | 7611DEN2014 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
